APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antithyroid Preparations

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antithyroid Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025190 pages

Choose your research edition.

Industry ResearchAntithyroid Preparations Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithyroid Preparations Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Antithyroid Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithyroid Preparations Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithyroid Preparations Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Antithyroid Preparations market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antithyroid Preparations include Taishan Xinning Pharmaceutical Co., Ltd., Shenzhen Zhonglian Pharmaceutical Co., Ltd., Shanghai Xinyi Tianping Pharmaceutical Co., Ltd., Shanghai Zhaohui Pharmaceutical Co., Ltd., Sanmenxia Sinovi Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Liaoning Kangbo Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd. and Jinghua Pharmaceutical Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antithyroid Preparations market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antithyroid Preparations and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antithyroid Preparations sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antithyroid Preparations market size, projected growth trends, production technologies, key applications, and end-use industries.

Antithyroid Preparations Segment by Company

Taishan Xinning Pharmaceutical Co., Ltd.

Shenzhen Zhonglian Pharmaceutical Co., Ltd.

Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd.

Sanmenxia Sinovi Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Liaoning Kangbo Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jinghua Pharmaceutical Group Co., Ltd.

Jinyao Pharmaceutical Co., Ltd.

Hunan Xiangzhong Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Guizhou Shengjitang Pharmaceutical Co., Ltd.

Guangzhou Kanghe Pharmaceutical Co., Ltd.

Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.

Guangdong South China Pharmaceutical Group Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Beijing Yongkang Pharmaceutical Co., Ltd.

Beijing Jialin Pharmaceutical Co., Ltd.

Beijing Beiwei Pharmaceutical Co., Ltd.

Upsher-Smith Laboratories, LLC

Teva

Pfizer

Avet Pharmaceuticals Inc.

Antithyroid Preparations Segment by Type

Propylthiouracil

Methimazole

Antithyroid Preparations Segment by Application

Hospital

Clinic

Other

Antithyroid Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antithyroid Preparations market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antithyroid Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antithyroid Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antithyroid Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antithyroid Preparations Industry Trends Table 2. Antithyroid Preparations Industry Drivers Table 3. Antithyroid Preparations Industry Opportunities and Challenges Table 4. Antithyroid Preparations Industry Restraints Table 5. Global Antithyroid Preparations Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antithyroid Preparations Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antithyroid Preparations Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antithyroid Preparations Sales Market Share by Manufacturers Table 9. Global Antithyroid Preparations Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antithyroid Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antithyroid Preparations Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antithyroid Preparations Manufacturers, Product Type & Application Table 13. Global Antithyroid Preparations Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antithyroid Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Propylthiouracil Table 17. Major Manufacturers of Methimazole Table 18. Global Antithyroid Preparations Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 20. Global Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 21. Global Antithyroid Preparations Sales Market Share by Type (2021-2026) Table 22. Global Antithyroid Preparations Sales Market Share by Type (2027-2032) Table 23. Global Antithyroid Preparations Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Antithyroid Preparations Revenue by Type (2021-2026) & (K Units) Table 25. Global Antithyroid Preparations Revenue by Type (2027-2032) & (K Units) Table 26. Global Antithyroid Preparations Revenue Market Share by Type (2021-2026) Table 27. Global Antithyroid Preparations Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Antithyroid Preparations Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 33. Global Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 34. Global Antithyroid Preparations Sales Market Share by Application (2021-2026) Table 35. Global Antithyroid Preparations Sales Market Share by Application (2027-2032) Table 36. Global Antithyroid Preparations Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Antithyroid Preparations Revenue by Application (2021-2026) & (K Units) Table 38. Global Antithyroid Preparations Revenue by Application (2027-2032) & (K Units) Table 39. Global Antithyroid Preparations Revenue Market Share by Application (2021-2026) Table 40. Global Antithyroid Preparations Revenue Market Share by Application (2027-2032) Table 41. Global Antithyroid Preparations Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Antithyroid Preparations Sales by Region (2021-2026) & (K Units) Table 43. Global Antithyroid Preparations Sales Market Share by Region (2021-2026) Table 44. Global Antithyroid Preparations Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Antithyroid Preparations Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 48. North America Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 49. Europe Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 51. Europe Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 58. Global Antithyroid Preparations Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antithyroid Preparations Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Antithyroid Preparations Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Antithyroid Preparations Revenue Market Share by Region (2021-2026) Table 62. Global Antithyroid Preparations Revenue Market Share by Region (2027-2032) Table 63. Taishan Xinning Pharmaceutical Co., Ltd. Company Information Table 64. Taishan Xinning Pharmaceutical Co., Ltd. Business Overview Table 65. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 67. Taishan Xinning Pharmaceutical Co., Ltd. Recent Development Table 68. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information Table 69. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview Table 70. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 72. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Development Table 73. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information Table 74. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview Table 75. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 77. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Development Table 78. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information Table 79. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview Table 80. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 82. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Development Table 83. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information Table 84. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview Table 85. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 87. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Development Table 88. Qilu Pharmaceutical Co., Ltd. Company Information Table 89. Qilu Pharmaceutical Co., Ltd. Business Overview Table 90. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 92. Qilu Pharmaceutical Co., Ltd. Recent Development Table 93. Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information Table 94. Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview Table 95. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 97. Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Development Table 98. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 99. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 100. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 102. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Development Table 103. Jinghua Pharmaceutical Group Co., Ltd. Company Information Table 104. Jinghua Pharmaceutical Group Co., Ltd. Business Overview Table 105. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 107. Jinghua Pharmaceutical Group Co., Ltd. Recent Development Table 108. Jinyao Pharmaceutical Co., Ltd. Company Information Table 109. Jinyao Pharmaceutical Co., Ltd. Business Overview Table 110. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 112. Jinyao Pharmaceutical Co., Ltd. Recent Development Table 113. Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information Table 114. Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview Table 115. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 117. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Development Table 118. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 119. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 120. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 122. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 123. Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information Table 124. Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview Table 125. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 127. Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Development Table 128. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information Table 129. Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview Table 130. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 132. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Development Table 133. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information Table 134. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview Table 135. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 137. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Development Table 138. Guangdong South China Pharmaceutical Group Co., Ltd. Company Information Table 139. Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview Table 140. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 142. Guangdong South China Pharmaceutical Group Co., Ltd. Recent Development Table 143. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 144. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 145. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 147. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 148. Beijing Yongkang Pharmaceutical Co., Ltd. Company Information Table 149. Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview Table 150. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 152. Beijing Yongkang Pharmaceutical Co., Ltd. Recent Development Table 153. Beijing Jialin Pharmaceutical Co., Ltd. Company Information Table 154. Beijing Jialin Pharmaceutical Co., Ltd. Business Overview Table 155. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 157. Beijing Jialin Pharmaceutical Co., Ltd. Recent Development Table 158. Beijing Beiwei Pharmaceutical Co., Ltd. Company Information Table 159. Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview Table 160. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 162. Beijing Beiwei Pharmaceutical Co., Ltd. Recent Development Table 163. Upsher-Smith Laboratories, LLC Company Information Table 164. Upsher-Smith Laboratories, LLC Business Overview Table 165. Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio Table 167. Upsher-Smith Laboratories, LLC Recent Development Table 168. Teva Company Information Table 169. Teva Business Overview Table 170. Teva Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Teva Antithyroid Preparations Product Portfolio Table 172. Teva Recent Development Table 173. Pfizer Company Information Table 174. Pfizer Business Overview Table 175. Pfizer Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Pfizer Antithyroid Preparations Product Portfolio Table 177. Pfizer Recent Development Table 178. Avet Pharmaceuticals Inc. Company Information Table 179. Avet Pharmaceuticals Inc. Business Overview Table 180. Avet Pharmaceuticals Inc. Antithyroid Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio Table 182. Avet Pharmaceuticals Inc. Recent Development Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Antithyroid Preparations Distributors List Table 186. Antithyroid Preparations Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Antithyroid Preparations Product Image Figure 2. Global Antithyroid Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithyroid Preparations Market Size (2021-2032) & (US$ Million) Figure 4. Global Antithyroid Preparations Sales (2021-2032) & (K Units) Figure 5. Global Antithyroid Preparations Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antithyroid Preparations Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Propylthiouracil Image Figure 9. Methimazole Image Figure 10. Global Antithyroid Preparations Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Antithyroid Preparations Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Antithyroid Preparations Sales Market Share by Type (2021-2032) Figure 13. Global Antithyroid Preparations Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Antithyroid Preparations Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Antithyroid Preparations Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Antithyroid Preparations Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Antithyroid Preparations Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antithyroid Preparations Sales Market Share by Application (2021-2032) Figure 22. Global Antithyroid Preparations Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Antithyroid Preparations Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Antithyroid Preparations Revenue Market Share by Application (2021-2032) Figure 25. North America Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 27. U.S. Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 32. Germany Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 39. China Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 47. Brazil Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Antithyroid Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Antithyroid Preparations Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Antithyroid Preparations Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Figure 58. North America Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Figure 60. Europe Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Antithyroid Preparations Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Antithyroid Preparations Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Propylthiouracil
  • Methimazole
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Taishan Xinning Pharmaceutical Co., Ltd.
  • Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  • Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  • Shanghai Zhaohui Pharmaceutical Co., Ltd.
  • Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Liaoning Kangbo Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jinghua Pharmaceutical Group Co., Ltd.
  • Jinyao Pharmaceutical Co., Ltd.
  • Hunan Xiangzhong Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Guizhou Shengjitang Pharmaceutical Co., Ltd.
  • Guangzhou Kanghe Pharmaceutical Co., Ltd.
  • Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  • Guangdong South China Pharmaceutical Group Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Beijing Yongkang Pharmaceutical Co., Ltd.
  • Beijing Jialin Pharmaceutical Co., Ltd.
  • Beijing Beiwei Pharmaceutical Co., Ltd.
  • Upsher-Smith Laboratories, LLC
  • Teva
  • Pfizer
  • Avet Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antithyroid Preparations Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antithyroid Preparations Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antithyroid Preparations Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antithyroid Preparations Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antithyroid Preparations Market Dynamics
  1. 2.1 Antithyroid Preparations Industry Trends
  2. 2.2 Antithyroid Preparations Industry Drivers
  3. 2.3 Antithyroid Preparations Industry Opportunities and Challenges
  4. 2.4 Antithyroid Preparations Industry Restraints
3 Antithyroid Preparations Market by Manufacturers
  1. 3.1 Global Antithyroid Preparations Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antithyroid Preparations Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antithyroid Preparations Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antithyroid Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antithyroid Preparations Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antithyroid Preparations Manufacturers, Product Type & Application
  7. 3.7 Global Antithyroid Preparations Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antithyroid Preparations Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antithyroid Preparations Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antithyroid Preparations Tier 1, Tier 2, and Tier 3
4 Antithyroid Preparations Market by Type
  1. 4.1 Antithyroid Preparations Type Introduction
  2. 4.1.1 Propylthiouracil
  3. 4.1.2 Methimazole
  4. 4.2 Global Antithyroid Preparations Sales by Type
  5. 4.2.1 Global Antithyroid Preparations Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antithyroid Preparations Sales by Type (2021-2032)
  7. 4.2.3 Global Antithyroid Preparations Sales Market Share by Type (2021-2032)
  8. 4.3 Global Antithyroid Preparations Revenue by Type
  9. 4.3.1 Global Antithyroid Preparations Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Antithyroid Preparations Revenue by Type (2021-2032)
  11. 4.3.3 Global Antithyroid Preparations Revenue Market Share by Type (2021-2032)
5 Antithyroid Preparations Market by Application
  1. 5.1 Antithyroid Preparations Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Antithyroid Preparations Sales by Application
  6. 5.2.1 Global Antithyroid Preparations Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antithyroid Preparations Sales by Application (2021-2032)
  8. 5.2.3 Global Antithyroid Preparations Sales Market Share by Application (2021-2032)
  9. 5.3 Global Antithyroid Preparations Revenue by Application
  10. 5.3.1 Global Antithyroid Preparations Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antithyroid Preparations Revenue by Application (2021-2032)
  12. 5.3.3 Global Antithyroid Preparations Revenue Market Share by Application (2021-2032)
6 Global Antithyroid Preparations Sales by Region
  1. 6.1 Global Antithyroid Preparations Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antithyroid Preparations Sales by Region (2021-2032)
  3. 6.2.1 Global Antithyroid Preparations Sales by Region (2021-2026)
  4. 6.2.2 Global Antithyroid Preparations Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antithyroid Preparations Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antithyroid Preparations Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antithyroid Preparations Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antithyroid Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antithyroid Preparations Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antithyroid Preparations Revenue by Region
  1. 7.1 Global Antithyroid Preparations Revenue by Region
  2. 7.1.1 Global Antithyroid Preparations Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antithyroid Preparations Revenue by Region (2021-2026)
  4. 7.1.3 Global Antithyroid Preparations Revenue by Region (2027-2032)
  5. 7.1.4 Global Antithyroid Preparations Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antithyroid Preparations Revenue (2021-2032)
  8. 7.2.2 North America Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antithyroid Preparations Revenue (2021-2032)
  11. 7.3.2 Europe Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antithyroid Preparations Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antithyroid Preparations Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antithyroid Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Taishan Xinning Pharmaceutical Co., Ltd.
  2. 8.1.1 Taishan Xinning Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Taishan Xinning Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  6. 8.1.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  8. 8.2.1 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  12. 8.2.5 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  14. 8.3.1 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  18. 8.3.5 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shanghai Zhaohui Pharmaceutical Co., Ltd.
  20. 8.4.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  24. 8.4.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  26. 8.5.1 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  30. 8.5.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Qilu Pharmaceutical Co., Ltd.
  32. 8.6.1 Qilu Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  36. 8.6.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Liaoning Kangbo Pharmaceutical Co., Ltd.
  38. 8.7.1 Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  42. 8.7.5 Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Liaoning Dongyi Pharmaceutical Co., Ltd.
  44. 8.8.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  48. 8.8.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jinghua Pharmaceutical Group Co., Ltd.
  50. 8.9.1 Jinghua Pharmaceutical Group Co., Ltd. Company Information
  51. 8.9.2 Jinghua Pharmaceutical Group Co., Ltd. Business Overview
  52. 8.9.3 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  54. 8.9.5 Jinghua Pharmaceutical Group Co., Ltd. Recent Developments
  55. 8.10 Jinyao Pharmaceutical Co., Ltd.
  56. 8.10.1 Jinyao Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jinyao Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  60. 8.10.5 Jinyao Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Hunan Xiangzhong Pharmaceutical Co., Ltd.
  62. 8.11.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  66. 8.11.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hunan Hansen Pharmaceutical Co., Ltd.
  68. 8.12.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  72. 8.12.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Guizhou Shengjitang Pharmaceutical Co., Ltd.
  74. 8.13.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  78. 8.13.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Guangzhou Kanghe Pharmaceutical Co., Ltd.
  80. 8.14.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  84. 8.14.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  86. 8.15.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information
  87. 8.15.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
  88. 8.15.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  90. 8.15.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
  91. 8.16 Guangdong South China Pharmaceutical Group Co., Ltd.
  92. 8.16.1 Guangdong South China Pharmaceutical Group Co., Ltd. Company Information
  93. 8.16.2 Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview
  94. 8.16.3 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  96. 8.16.5 Guangdong South China Pharmaceutical Group Co., Ltd. Recent Developments
  97. 8.17 Beijing Taiyang Pharmaceutical Co., Ltd.
  98. 8.17.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  102. 8.17.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Beijing Yongkang Pharmaceutical Co., Ltd.
  104. 8.18.1 Beijing Yongkang Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  108. 8.18.5 Beijing Yongkang Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Beijing Jialin Pharmaceutical Co., Ltd.
  110. 8.19.1 Beijing Jialin Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Beijing Jialin Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  114. 8.19.5 Beijing Jialin Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Beijing Beiwei Pharmaceutical Co., Ltd.
  116. 8.20.1 Beijing Beiwei Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  120. 8.20.5 Beijing Beiwei Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Upsher-Smith Laboratories, LLC
  122. 8.21.1 Upsher-Smith Laboratories, LLC Company Information
  123. 8.21.2 Upsher-Smith Laboratories, LLC Business Overview
  124. 8.21.3 Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio
  126. 8.21.5 Upsher-Smith Laboratories, LLC Recent Developments
  127. 8.22 Teva
  128. 8.22.1 Teva Company Information
  129. 8.22.2 Teva Business Overview
  130. 8.22.3 Teva Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Teva Antithyroid Preparations Product Portfolio
  132. 8.22.5 Teva Recent Developments
  133. 8.23 Pfizer
  134. 8.23.1 Pfizer Company Information
  135. 8.23.2 Pfizer Business Overview
  136. 8.23.3 Pfizer Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Pfizer Antithyroid Preparations Product Portfolio
  138. 8.23.5 Pfizer Recent Developments
  139. 8.24 Avet Pharmaceuticals Inc.
  140. 8.24.1 Avet Pharmaceuticals Inc. Company Information
  141. 8.24.2 Avet Pharmaceuticals Inc. Business Overview
  142. 8.24.3 Avet Pharmaceuticals Inc. Antithyroid Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio
  144. 8.24.5 Avet Pharmaceuticals Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antithyroid Preparations Value Chain Analysis
  2. 9.1.1 Antithyroid Preparations Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antithyroid Preparations Production Mode & Process
  6. 9.2 Antithyroid Preparations Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antithyroid Preparations Distributors
  9. 9.2.3 Antithyroid Preparations Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst